Skip to main content
Equibles
PLUR logo

PLUR · Pluri Inc.

Track PLUR — free

Use PLUR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PLUR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.08 -0.06 (-5.26%)
Rebalance outlook locked
Going-concern doubt — flagged Sep 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“According to management estimates, we have sufficient resources to meet our operating obligations for a period of less than three months from the issuance date of our consolidated financial statements, which was September 10, 2026. These conditions raise substantial doubt about our ability to continue as a going concern.”
View the 10-K filed Sep 10, 2026
Market Cap
$15.49M
Shares
12.34M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.14 Open$1.19 Day$1.10–1.29 52W close$1.14–4.89 Avg vol 30d25K Short int26K · 0.2% float · 1.0d Short vol41% DataJan 2020–Sep 2026 Filing10-K · Sep 10

Up next

Latest filing: 10-K
filed Sep 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.02M
Trailing 12 months
Net income (TTM)
−$23.82M
Trailing 12 months
Revenue growth YoY
-15.8%
Year over year
Operating margin
-2,454.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-130.5%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+53.2%
Year over year · more shares
Price change (1Y)
-76.0%
Trailing year
Short interest
0.2%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 17.7 · elevated Equity put/call 0.69
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −58%
below
Price vs 50-day avg −29%
below
RSI (14) 32
neutral
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −30%
trailing
6-month return −63%
trailing
YTD return −62%
this year
Relative strength −77%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.21% of float · ▲ +70.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
16 holders — mid 3-yr range
Squeeze score 37
low risk · 0–100
Fundamentals
Fair
Revenue growth −24%
Y/Y
Gross margin 45%
contracting
EPS growth +31%
Y/Y
Free cash flow $-20.2M
Quant / Vol
risk profile
Very High
Volatility 72%
annualized · 1-yr
Max drawdown −77%
past year
ATR 12.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−58% Bearish
Price vs 50-day avg
−29% Bearish
RSI (14)
32 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.21% of float · ▲ +70.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
16 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 0% Range high $5
vs 200-day avg -58% vs 50-day avg -29%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PLUR
Pluri Inc.
this stock
$15.49M -61.9% -24.0% — 0.2%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.06B +13.2% +46.2% 29.9 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $79.83B +0.4% +20.8% 19.2 2.5%
ARGX
Argenx SE
 $60.93B +17.1% — — 2.0%
CSLLY
Csl Ltd
 $59.64B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
16
% held
0.2%
Net QoQ
-439 sh
Top holder
RENAISSANCE TECHNOLOGIES…
Held Float
View
Held by Funds
Fund positions
2
View
Short & Settlement
Short Interest Rising
Shares short
26.5K
Days to cover
1.0d
Change
+10.9K sh
View
Short Volume
Short vol %
41%
As of
Sep 16, 2026
Short Total
View
Fails to Deliver
FTD shares
1.4K
Value
$2.1K
As of
Aug 28, 2026
View
Off-Exchange
Off-exchange %
45.0%
Week of
Aug 10, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.0M
Net income (FY)
$-23.8M
EPS diluted
$-2.44
View
Filings
SEC Filings
Latest
10-K
Filed
Sep 10, 2026
This year
13
View
Exempt Offerings
Offering
$3.7M
Filed
Sep 4, 2026
View

Performance

5D 20D 120D MTD YTD
PLUR -16.8% -30.1% -62.6% -22.5% -61.9%
SPY -1.1% -1.8% +14.8% -1.7% +10.6%
vs SPY -15.7% -28.3% -77.4% -20.8% -72.5%
Key facts CIK 1158780 CUSIP 72942G203 Visit website Investor relations